Brief: Trans Genic receives patent in US
19/12/2016 06:33
Dec 19 (Reuters) - Trans Genic Inc 2342.T :
* Says co and National Cancer Center Japan received a patent
in the U.S., for a kind of antibody for lung cancer and relevant
diagnostic application
Source text in Japanese: https://goo.gl/8ZNGeW
Further company coverage: 2342.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))